3409 results for «2023»
3409 results
Calcified lesions: caught between a rock and a hard place
10 Dec 2025 – From GulfPCR-GIM 2025
This session focuses on the challenges of treating calcified coronary lesions, emphasizing the use of intravascular ultrasound (IVUS)-guided rotablation and the limitations of rotatripsy in complex bifurcation angioplasty. It covers innovative strategies including off-label Shockwave lithotripsy in stented lesions, management of calcified nodules, and approaches to...
Imaging to the rescue
11 Dec 2025 – From GulfPCR-GIM 2025
This session highlighted the pivotal role of advanced intracoronary imaging techniques, particularly OCT, in complex case management such as in-stent restenosis and thrombus evaluation. Through real-world cases, it demonstrated how imaging complements physiology to guide therapeutic decisions, including the use of drug-coated balloons beyond native coronary...
Coronary Pot Pourri - 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session presents a diverse range of complex coronary interventions, highlighting advanced techniques and strategies. Topics include the use of ECMO support for high-risk PCI and TAVI in cardiogenic shock, innovative approaches in left main interventions, challenging stent optimisation, and management of patients with combined severe...
Challenging CTO Interventions - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session addresses the complexities of chronic total occlusion (CTO) interventions with a collection of challenging cases employing advanced techniques. Topics include IVUS-assisted recanalisation, hybrid approaches incorporating 3D wiring, retrograde interventions after antegrade failure, and management of procedural complications such as vessel rupture. The session also...
Abstracts - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session compiles recent clinical abstracts addressing diverse topics in interventional cardiology. Highlights include the HYBRID-CTO approach from a prospective case series, the cardiovascular impact of empagliflozin in type 2 diabetes, off-label use of intravascular lithotripsy for resistant in-stent lesions, and experiences with non-hyperaemic pressure ratios...
Innovation and teamwork in structural heart interventions
11 Dec 2025 – From GulfPCR-GIM 2025
This session explores innovations and collaborative approaches in structural heart interventions, focusing on aortic and mitral valve procedures. It addresses procedural indications, challenges, and the evolving roles of non-physician allied professionals. Interactive elements foster knowledge exchange and support the growth of expertise in the structural heart...
Challenging STEMI scenarios - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session presents complex STEMI cases that highlight the challenges of acute coronary syndrome management, including difficult arterial access, balancing reperfusion with embolization risks, and rare complications such as spontaneous coronary artery dissections. It emphasizes nuanced decision-making in high-stakes clinical scenarios.
TEER versus mitral surgery: Data from a nationwide analysis
26 Aug 2023
Alessandro Sticchi interviews Pierre Deharo about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam.
When comparing long-term outcomes of transcatheter edge-to-edge repair (TEER) versus isolated mitral valve repair surgery, the analysis revealed that cardiovascular death was lower among...
Author
Author
STOPDAPT-3: an aspirin-free antithrombotic strategy for percutaneous coronary intervention
28 Aug 2023
Aaysha Cader interviews Masahiro Natsuaki about the design and results of the STOPDAPT-3 trial which he presented during the ESC Congress 2023 in Amsterdam.
Prasugrel monotherapy after PCI with drug-eluting stents was not superior to dual-antiplatelet therapy (DAPT) for major bleeding but was non-inferior for cardiovascular events...
Author
Author
CLASP IID one-year outcomes - Transcatheter edge-to-edge repair systems for degenerative MR
27 Oct 2023
Alessandro Sticchi interviews Robert L. Smith & Firas Zahr about the CLASP IID Trial and Registry which they presented during the TCT Congress 2023 in San Francisco.
The PASCAL system proved effective in treating high-risk patients with symptomatic degenerative mitral regurgitation, meeting primary and secondary endpoints while improving...
Author
Author
Author
TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR
27 Oct 2023
Mirvat Alasnag interviews Susheel K. Kodali about the results of the TRISCEND II trial which he presented during the TCT Congress 2023 in San Francisco.
Data from the first 150 patients revealed that transcatheter valve replacement effectively improved tricuspid regurgitation and patient symptoms with low adverse events at...
Author
Author
How to support the equal advancement of women in interventional cardiology
18 May 2023 – From EuroPCR 2023
Roxana Mehran, Marta Bande and Emanuele Barbato tackle the issue of gender equity: how to create a more equitable environment for women interventional cardiologists, and how to support women in the field of interventional cardiology as a whole. They also discuss the key drivers of change...
PCR Perspectives - a contemporary approach to the invasive diagnosis of MINOCA
17 May 2023 – From EuroPCR 2023
Nina Van Der Hoeven and Colin Berry seize the opportunity of meeting at the heart of EuroPCR 2023 to discuss the diagnostic approach of MINOCA. As they explain, everything is primarily determined in the cathlab, thanks to angiograms. Further investigations are then required to exclude other causes than...
Durability of surgical and transcatheter valves, what do we know so far?
16 May 2023 – From EuroPCR 2023
We have significant new data that highlights the long-lasting effectiveness of transcatheter devices, which brings forth a promising possibility of them competing with surgical valves in the next generation. Take part in a discussion with Bernard Prendergast and Raj Makkar as they analyze the data available so far...
The PECTUS trial, OCT for identification of vulnerable plaques and its impact on clinical outcomes
16 May 2023 – From EuroPCR 2023
Niels Van Royen and Lorenz Räber discuss a very emerging topic: the vulnerable plaque, and more specifically the related PECTUS Trial. They address the question of why vulnerable plaques should be detected and what can be done with the results, before looking at the study design...
Latest evidences and experiences on ultra-thin strut stenting
17 May 2023 – From EuroPCR 2023
Suhas Hardas, Anupam Jena and Rajneesh Kapoor discuss ultra-thin strut stent technology.
When do we really call the new-generation stents "ultra-thin strut strents"? Why do we need stents of this type? Which lesions, or which patients, will they be most useful and effective for?
Find out more about...
Learnings and perspectives from the Asian STEMI Registry
16 May 2023 – From EuroPCR 2023
Deanna Khoo invites Paul Ong and Michael K. Y. Lee, the Principal Investigators of the study, to present the results of the BioFreedom Asian Registry, which focused on the management of STEMI patients in Asia.
Find out more about the study design, before discovering the main outcomes!
This interview...
At PCR, it’s all about people!
17 May 2023
EuroPCR – the 2023 edition – has been prepared with a new Core Team. Indeed, Jean Fajadet and William Wijns invited three new Course Directors to join them in this role at the end of last year. It was all part of a general reorganisation of PCR’s structure, during...
EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!
20 May 2025
Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...
Introducing our recognised EuroPCR Networkers!
